Prognostic impact of initial maximum standardized uptake value of F-18-FDG PET/CT on treatment response in patients with metastatic lung adenocarcinoma treated with erlotinib

---

Kus T., Aktas G., Sevinc A., KALENDER M. E., YILMAZ M., KUL S., ...More

ONCOTARGETS AND THERAPY, vol.8, pp.3749-3756, 2015 (SCI-Expanded)

• Publication Type: Article / Article
• Volume: 8
• Publication Date: 2015
• Doi Number: 10.2147/ott.s94945
• Journal Name: ONCOTARGETS AND THERAPY
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Page Numbers: pp.3749-3756
• Keywords: lung adenocarcinoma, erlotinib, F-18-fluorodeoxyglucose positron emission tomography/computed tomography, maximum standardized uptake value, treatment response, prognosis, PLATINUM-BASED CHEMOTHERAPY, OPEN-LABEL, PHASE-III, 2ND-LINE TREATMENT, SMOKING HISTORY, SUPPORTIVE CARE, EGFR MUTATIONS, CANCER, GEFITINIB, MULTICENTER
• Open Archive Collection: AVESIS Open Access Collection
• Akdeniz University Affiliated: Yes

Abstract

Purpose: To investigate whether the initial maximum standardized uptake value (SUVmax) on fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography (F-18-FDG PET/CT) has a prognostic significance in metastatic lung adenocarcinoma.